PTPκ Inhibitors are a class of chemical compounds that target and inhibit the activity of protein tyrosine phosphatase kappa (PTPκ), an enzyme belonging to the protein tyrosine phosphatase (PTP) family. PTPκ is a transmembrane receptor-type phosphatase that plays a critical role in cellular signaling pathways by dephosphorylating specific tyrosine residues on target proteins. This dephosphorylation process is essential for regulating various cellular functions, including cell adhesion, migration, and signaling cascades involved in cell growth and differentiation. PTPκ is particularly noted for its involvement in the regulation of cadherin-mediated cell-cell adhesion, a fundamental process in maintaining tissue architecture and integrity.
The use of PTPκ Inhibitors in research allows scientists to investigate the complex signaling networks that PTPκ influences, particularly those related to cell-cell communication and the maintenance of epithelial cell integrity. By inhibiting PTPκ activity, researchers can explore the downstream effects on cadherin-mediated adhesion and how disruptions in this process can affect cellular behavior. These inhibitors are valuable tools for studying the dynamics of cell adhesion molecules and their role in tissue morphogenesis, wound healing, and cellular response to environmental changes. Additionally, PTPκ Inhibitors provide insights into the broader regulatory mechanisms of tyrosine phosphorylation and dephosphorylation in cellular signaling networks, offering a deeper understanding of how cells coordinate their functions and maintain homeostasis. Overall, PTPκ Inhibitors are critical for advancing knowledge in cell biology, particularly in areas related to cell adhesion, signaling, and the intricate balance of phosphorylation states that govern cellular processes.
Items 1 to 10 of 16 total
디스플레이 라벨:
제품명 | CAS # | 카탈로그 번호 | 수량 | 가격 | 引用 | RATING |
---|---|---|---|---|---|---|
Imatinib | 152459-95-5 | sc-267106 sc-267106A sc-267106B | 10 mg 100 mg 1 g | $25.00 $117.00 $209.00 | 27 | |
PTPR 활성 부위에 결합하여 효소 활성을 방지함으로써 PTPR 활성을 억제합니다. | ||||||
Dasatinib | 302962-49-8 | sc-358114 sc-358114A | 25 mg 1 g | $47.00 $145.00 | 51 | |
PTPR 인산화 및 활성화를 차단하여 신호 전달 기능을 감소시킵니다. | ||||||
Nilotinib | 641571-10-0 | sc-202245 sc-202245A | 10 mg 25 mg | $205.00 $405.00 | 9 | |
키나아제 도메인에 결합하여 자가 인산화를 방지함으로써 PTPR 활성을 억제합니다. | ||||||
AP 24534 | 943319-70-8 | sc-362710 sc-362710A | 10 mg 50 mg | $172.00 $964.00 | 2 | |
PTPR 및 기타 키나아제를 표적으로 삼아 활성화 및 다운스트림 신호를 억제합니다. | ||||||
Sunitinib, Free Base | 557795-19-4 | sc-396319 sc-396319A | 500 mg 5 g | $150.00 $920.00 | 5 | |
인산화 및 활성화를 억제하여 PTPR 신호 전달을 방해합니다. | ||||||
Sorafenib | 284461-73-0 | sc-220125 sc-220125A sc-220125B | 5 mg 50 mg 500 mg | $56.00 $260.00 $416.00 | 129 | |
키나아제 도메인을 억제하여 PTPR 매개 신호 캐스케이드를 방해합니다. | ||||||
Regorafenib | 755037-03-7 | sc-477163 sc-477163A | 25 mg 50 mg | $320.00 $430.00 | 3 | |
키나아제 도메인을 차단하여 PTPR 활성을 억제하여 다운스트림 효과를 방해합니다. | ||||||
Ibrutinib | 936563-96-1 | sc-483194 | 10 mg | $153.00 | 5 | |
PTPR 및 기타 키나아제를 표적으로 하여 신호 기능을 손상시킵니다. | ||||||
Acalabrutinib | 1420477-60-6 | sc-507392 | 250 mg | $255.00 | ||
키나아제 도메인에 결합하여 활성화를 방지함으로써 PTPR 신호 전달을 억제합니다. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $45.00 $56.00 $183.00 | 142 | |
단백질 티로신 포스파타제의 비특이적 억제제로 알려져 있으며, 효소 및 프라임 기질의 전이 상태를 모방하여 PTPR 활성을 억제할 수 있습니다. |